SCHEMBL8301095

SCHEMBL8301095

CCCS(=O)(=O)Nc1ccc(NS(=O)(=O)CCC)c(Oc2cccc3ccccc23)c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 1/20 0.53
NCOA3 Q9Y6Q9 1/20 0.53
BRD4 O60885 4/20 0.46
LY6K Q17RY6 1/20 0.45
PTGS1 P23219 1/20 0.44
CYP17A1 P05093 2/20 0.43
KDR P35968 2/20 0.42
AURKA O14965 1/20 0.42
AURKB Q96GD4 1/20 0.42
ESRRA P11474 1/20 0.41
PARP14 Q460N5 1/20 0.41
LRRK2 Q5S007 1/20 0.41
MRGPRX1 Q96LB2 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2B Q13224 1/20 0.40
BRAF P15056 2/20 0.39
KIT P10721 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8301094 0.82 PARP14 (0.46) RAD52NCOA3BRD4PTGS1KDR
SCHEMBL7222256 0.78 BRD4 (0.47) RAD52NCOA3BRD4CYP17A1KDR
SCHEMBL7220116 0.77 BCL2L1 (0.48) BRD4KDRAURKAAURKBESRRA
SCHEMBL7221513 0.76 BRD4 (0.45) RAD52NCOA3BRD4KDRAURKA
SCHEMBL7226423 0.76 MRGPRX1 (0.45) RAD52NCOA3BRD4KDRAURKA
SCHEMBL8307237 0.76 AR (0.56) BRD4KDRAURKAAURKBMRGPRX1
SCHEMBL7222716 0.76 MRGPRX1 (0.54) RAD52NCOA3BRD4PTGS1KDR
SCHEMBL7467297 0.73 HPGD (0.43) RAD52NCOA3BRD4CYP17A1KDR
SCHEMBL7228204 0.69 PGR (0.51) CYP17A1BRAF
SCHEMBL7219476 0.69 MRGPRX1 (0.52) MRGPRX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966436-A1 ARYL SULFONAMIDES AND ANALOGUES THEREOF AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES Bayer Aktiengesellschaft (DE) 1999-12-29 EP disclosed
WO-1998037061-A1 ARYL SULFONAMIDES AND ANALOGUES THEREOF AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES BAYER AKTIENGESELLSCHAFT (DE) 1998-08-27 WO disclosed